+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Long-term morbidity and mortality after cardiac transplantation Interaction with immunosuppression and graft rejection

Long-term morbidity and mortality after cardiac transplantation Interaction with immunosuppression and graft rejection

European Heart Journal 24(Abstract Suppl.): 617, August-September

(PDF emailed within 1 workday: $29.90)

Accession: 035236945

Download citation: RISBibTeXText

Related references

Long-term morbidity of cyclosporine with corticosteroid-free maintenance immunosuppression in cardiac transplantation. Transplantation Proceedings 22(3 Suppl 1): 25-29, 1990

High-rate hepatitis and low-rate rejection induced late morbidity and mortality in long-term follow-up after liver transplantation. Transplantation Proceedings 30(5): 1828-1829, 1998

Hepatic Artery Reconstruction Prevents Ischemic Graft Injury, Inhibits Graft Rejection, and Mediates Long-term Graft Acceptance in Rat Liver Transplantation. Transplantation Proceedings 45(5): 1748-1753, 2013

Long-Term Cardiac Morbidity and Mortality in Patients With Aortic Valve Disease Following Liver Transplantation: A Case Matching Study. Seminars in Cardiothoracic and Vascular Anesthesia 21(4): 345-351, 2017

Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation. Journal of the American College of Cardiology 45(9): 1538-1542, 2005

Long-term morbidity and mortality in children with chronic graft-versus-host disease classified by National Institutes of Health consensus criteria after allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 2015

Experience in one center of combined kidney and liver transplantation in 22 patients: incidence of graft rejection and long-term graft outcome. Transplantation Proceedings 29(1-2): 243-244, 1997

Immunosuppression with antithymocyte globulin in renal transplantation: better long-term graft survival. Transplantation Proceedings 37(6): 2755-2758, 2005

European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.3.3. Long-term immunosuppression. Toxicity of immunosuppression. Nephrology, Dialysis, Transplantation 17 Suppl 4(): 21-23, 2002

Steroid-free immunosuppression regime reduces both long-term cardiovascular morbidity and patient mortality in renal transplant recipients. Clinical Transplantation 20(5): 571-581, 2006

Late antibody-mediated rejection after heart transplantation: Mortality, graft function, and fulminant cardiac allograft vasculopathy. Journal of Heart and Lung Transplantation 34(8): 1050-1057, 2016

Influence of time of rejection on long-term graft survival in renal transplantation. Transplantation 85(5): 661-666, 2008

Long term morbidity and mortality after kidney transplantation. Scandinavian Journal of Urology and Nephrology 26(4): 397-401, 1992

Cardiac transplantation with corticosteroid-free immunosuppression: Long-term result. Annals of Thoracic Surgery 52(2): 211-218, 1991

Cardiac transplantation with corticosteroid-free immunosuppression: long-term results. Annals of Thoracic Surgery 52(2): 211-7; Discussion 218, 1991